Nootropics Market - Databook 2025 to 2034

The global nootropics market size was evaluated at USD 8.61 billion in 2024 and is expected to grow around USD 33.21 billion by 2034, registering a CAGR of 14.45% from 2025 to 2034.

Highlights of the Nootropics Market

• North America dominated the global market in 2024.
• Asia Pacific is anticipated to grow at a notable rate in the market during the forecast period.
• By form insight, the capsules and tablets segment held a dominant presence in the market in 2024.
• By form insight, the powder segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By distribution channel insight, the offline distribution channel segment accounted for a considerable share of the market in 2024.
• By distribution channel insight, the online segment is projected to experience the highest growth rate in the market between 2025 and 2034.

Industry Valuation and Growth Rate Projection

The marketplace for nootropics is seeing considerable transformation because of increased consumer expectations for cognition and mental well-being. Drugs for improving cognition come under nootropics or smart drugs, comprising both natural and synthetic agents said to increase memory power, attention span, creative thinking, and mental alertness. With the lifelong proliferation of custom solutions, consumers now stack numerous nootropics to suit their needs to obtain the highest optimization of their applications.

The use of technology such as wearables and apps in any program of cognitive enhancement is but a manifestation of the populace's demand for a more holistic wellness solution. Discerning on the side of consumers in favor of popularizing nootropics are mental well-being awareness, general mounting stress, and just wanting to perform better on a mental level in an accelerated world. Cutting-edge research and innovation can establish a better understanding and broad credibility for the real benefits of nootropics. This, in turn, is what grooms the market with a blend of scientific advancements, lifestyle trends, and customers who yearn for a more personalized and holistic consideration for their cognitive and emotional well-being.

Nootropics Market: Stats and Figures

• Mind Lab Pro, a universal nootropic, is sold by Performance Lab Group. The company claims to have sold over a million bottles and states they make £10m in revenue a year.
• Neurohacker, a major player in the nootropics market, Collective reported over $20 million in total sales as of a 2020 document.

How AI Has Benefitted the Market?

• Personalized Formulation: It analyzes health data, lifestyle patterns, and markers to generate a personalized nootropic stack.
• Ingredient Optimization: Machine learning evaluates the effectiveness and compatibility of ingredients for safer formulation.
• Consumer Behavior Insight: AI tracks consumer preferences, obtains feedback, and monitors purchasing behavior for trend prediction and marketing.
• Monitoring and Real-Time Feedback: The AI interfaces with wearables and mobile applications to measure cognitive performance in real time.
• Faster R&D: AI predicts biological activity and optimizes clinical trial designs to make testing faster.

Industry Leader Announcements

• Kerrie Wade, director of marketing for ANZ at Swisse

“Nootropics are quite well established in the US, but something which we've seen a lot of emergence and interest in with Australian consumers.” “We’ve decided, as part of Swisse’s legacy, which is always to be innovative and to lead with science, we will trial and pioneer our range.”

• Spokesperson for WholisticResearch

“Nootropics are cognitive enhancing supplements and drugs that improve mental functions like memory, focus, creativity, and motivation in healthy individuals.”

Geographical Insights

North America

North America led the market in 2024. North America is the major player in the global market for nootropic substances, thereby resulting in the major contribution of the United States and Canada in the nootropic sphere. The region's inclination toward health, wellness, and cognitive performance has been instrumental in encouraging the growth of nootropic products. North American consumers highly appreciate supplements and functional products that claim to offer focus, mental clarity, and memory enhancement.

Asia-Pacific

Asia-Pacific is expected to witness notable growth in the market. Rapid urbanization and changing lifestyles in a burgeoning middle class with more disposable income constitute a notable market opportunity in Asia-Pacific for nootropics. Demand is generated in countries like Japan and South Korea by populations with heavy technological adoption and a culture that leans toward preventive health and natural cures. In general, the regional dynamics are very much design-oriented and adoption-oriented toward consumers when it comes to the globalized nootropics.

Europe

Europe is catching up with nootropics, being an Old-World herbal medicine and alternative treatment. European consumers lean towards protein enhancers of cognition from the natural origins industry for clean-label and health-focused products.

Recent Developments:

• In July 2024, WholisticResearch launched NootsAI™, a research assistant designed to aid individuals in understanding the mechanisms of nootropics and their benefits.
• In February 2022, Jones Soda, Wesana Health, and boxer Mike Tyson partnered to introduce a functional supplement experience, aiming to revolutionize neurological health and performance.

Competitive Landscape

The market is moderately fragmented with local players like Cerebral Success, Natural Stacks, OptiMind, TruBrain, Neurohacker Collective, Onnit, Mind Lab Pro, Nootropics Depot, Peak Nootropics, SmartX by CogniTune, wishing to take the time to edge their presence through investments, partnerships, acquisitions, and mergers. They also invest in product development and competitive pricing. These strategies will promote market growth and lucrative opportunities for market players

• Company Name: Cerebral Success
• Year of Incorporation: 2020
• Headquarters: Claymont, Delaware.

Cerebral Success (likely referring to BRAIN Biotech AG, a company also known for its brain health product SmartX) generated €54.6 million in revenue during the 2023/24 financial year.

• Company Name: Nootropics Depot
• Year of Incorporation: 2013
• Headquarters: Tempe, Arizona

According to Nootropics Depot's latest financial reports, the company's current revenue is $10 million.

• Company Name: Kloosterboer
• Year of Incorporation: 2015
• Headquarters: Carlsbad, California.

Neurohacker Collective's total sales are reported to be over $20 million.